الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - brinzolamid - øjendråber, suspension - 10 mg/ml

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiske midler - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukæmi, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcelle - protein kinase hæmmere - treatment of mantle cell lymphoma (mcl).

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - propofol - injektions-/infusionsvæske, emulsion - 10 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - ropivacainhydrochloridmonohydrat - injektions-/infusionsvæske, opløsning - 2 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - ropivacainhydrochloridmonohydrat - injektionsvæske, opløsning - 10 mg/ml

الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - ropivacainhydrochloridmonohydrat - injektionsvæske, opløsning - 7,5 mg/ml